Ionis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US4622221004

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Spencer R Berthelsen. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Spencer R Berthelsen har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:IONS / Ionis Pharmaceuticals, Inc. Director 156.013
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Spencer R Berthelsen. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb IONS / Ionis Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i IONS / Ionis Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IONS / Ionis Pharmaceuticals, Inc. Insider Trades
Insidersalg IONS / Ionis Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i IONS / Ionis Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-06-17 IONS BERTHELSEN SPENCER R 16.000 40,2900 16.000 40,2900 644.640 295 25.5100 -236.480 -36,68

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IONS / Ionis Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Spencer R Berthelsen som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-06-03 2026-06-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -8.000 156.013 -4,88 75,67 -605.360 11.805.504
2026-06-03 2026-06-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 8.000 164.013 5,13 24,42 195.360 4.005.197
2025-07-17 2025-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 4.079 156.013 2,68
2024-07-17 2024-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 4.677 151.934 3,18
2024-06-20 2024-06-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale -16.000 147.257 -9,80 40,29 -644.640 5.932.985
2024-06-20 2024-06-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 16.000 163.257 10,87 35,53 568.480 5.800.521
2023-07-19 2023-07-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.333 147.257 3,76
2023-07-19 2023-07-17 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 1.777 141.924 1,27
2023-06-22 2023-06-20 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 11.250 140.147 8,73 28,47 320.288 3.989.985
2022-07-19 2022-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 2.665 128.897 2,11
2022-07-19 2022-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.333 126.232 4,41
2022-06-09 2022-06-07 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 11.250 120.899 10,26 12,94 145.575 1.564.433
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise -1.778 9.775 -15,39
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise -666 11.553 -5,45
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise -889 12.219 -6,78
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
M - Exercise -5.333 13.108 -28,92
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 1.778 109.649 1,65
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 666 107.871 0,62
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 889 107.205 0,84
2021-07-19 2021-07-15 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.333 106.316 5,28
2021-07-06 2021-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Unit
A - Award 5.333 18.441 40,69
2021-07-06 2021-07-01 4 IONS IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12.000 12.000
2021-06-25 2021-06-23 4 IONS IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2021-06-25 2021-06-23 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -15.000 100.983 -12,93 37,74 -566.100 3.811.098
2021-06-25 2021-06-23 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 115.983 14,85 9,30 139.500 1.078.642
2020-07-06 2020-07-06 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -667 666 -50,04
2020-07-06 2020-07-06 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 100.983 0,66
2020-07-06 2020-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -889 1.777 -33,35
2020-07-06 2020-07-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 889 100.316 0,89
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 12.000 12.000
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 5.333 5.333
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -1.778 5.332 -25,01
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -666 0 -100,00
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 1.778 99.427 1,82
2020-07-06 2020-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 666 97.649 0,69
2020-06-25 2020-06-23 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2020-06-25 2020-06-23 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -15.000 96.983 -13,39 58,76 -881.400 5.698.721
2020-06-25 2020-06-23 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 111.983 15,47 9,22 138.300 1.032.483
2019-07-03 2019-07-03 4/A IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -667 1.333 -33,35
2019-07-03 2019-07-03 4/A IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 96.983 0,69
2019-07-03 2019-07-02 4/A IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -889 2.666 -25,01
2019-07-03 2019-07-02 4/A IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 889 96.316 0,93
2019-07-03 2019-07-01 4/A IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16.000 16.000
2019-07-03 2019-07-01 4/A IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 7.110 7.110
2019-07-03 2019-07-01 4/A IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -667 666 -50,04
2019-07-03 2019-07-01 4/A IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -666 0 -100,00
2019-07-03 2019-07-01 4/A IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 95.427 0,70
2019-07-03 2019-07-01 4/A IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 666 94.760 0,71
2019-06-26 2019-06-24 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2019-06-26 2019-06-24 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -9.690 94.094 -9,34 63,84 -618.639 6.007.243
2019-06-26 2019-06-24 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 9.690 103.784 10,30 16,32 158.141 1.693.755
2019-06-26 2019-06-24 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -5.310 94.094 -5,34 63,37 -336.474 5.962.370
2019-06-26 2019-06-24 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.310 99.404 5,64 16,32 86.659 1.622.273
2018-07-03 2018-07-03 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -667 2.000 -25,01
2018-07-03 2018-07-03 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 94.094 0,71
2018-07-03 2018-07-02 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16.000 16.000
2018-07-03 2018-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 3.555 3.555
2018-07-03 2018-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -2.000 1.999 -50,01
2018-07-03 2018-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 2.000 93.427 2,19
2018-06-25 2018-06-25 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2018-06-25 2018-06-25 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -9.300 91.427 -9,23 42,47 -394.971 3.882.905
2018-06-25 2018-06-25 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 9.300 100.727 10,17 13,88 129.084 1.398.091
2018-06-25 2018-06-25 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
S - Sale X -5.700 91.427 -5,87 42,03 -239.571 3.842.677
2018-06-25 2018-06-25 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.700 97.127 6,23 13,88 79.116 1.348.123
2017-07-03 2017-07-03 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16.000 16.000
2017-07-03 2017-07-03 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2.667 2.667
2017-07-03 2017-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -2.469 3.999 -38,17
2017-07-03 2017-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 2.469 91.427 2,78
2017-02-27 2017-02-24 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -12.500 0 -100,00
2017-02-27 2017-02-24 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 88.958 16,35 9,77 122.125 869.120
2016-07-06 2016-07-02 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -312 0 -100,00
2016-07-06 2016-07-02 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 312 76.458 0,41
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16.000 16.000
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2.667 2.667
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -1.803 3.801 -32,17
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 76.146 0,88
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 76.146 0,88
2016-07-06 2016-07-01 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 469 74.812 0,63
2016-02-22 2016-02-19 4 IONS IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -12.500 0 -100,00
2016-02-22 2016-02-19 4 IONS IONIS PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 74.343 20,21 5,93 74.125 440.854
2015-07-02 2015-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -312 312 -50,00
2015-07-02 2015-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 312 61.843 0,51
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16.000 16.000
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2.667 2.667
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -667 2.000 -25,01
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -469 937 -33,36
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 667 61.531 1,10
2015-07-02 2015-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 469 60.864 0,78
2015-04-17 2015-04-17 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise 10.000 0 -100,00
2015-04-17 2015-04-17 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 60.395 19,84 3,95 39.500 238.560
2014-07-02 2014-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -313 624 -33,40
2014-07-02 2014-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 313 50.395 0,62
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 16.000 16.000
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 2.667 2.667
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -469 1.406 -25,01
2014-07-02 2014-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 469 50.082 0,95
2014-04-17 2014-04-17 4 ISIS ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2014-04-17 2014-04-17 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 49.613 25,24 5,72 57.200 283.786
2013-07-03 2013-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -313 937 -25,04
2013-07-03 2013-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 313 39.613 0,80
2013-07-03 2013-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 1.875 1.875
2013-07-03 2013-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 11.250 11.250
2013-02-22 2013-02-21 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2013-02-22 2013-02-21 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 39.300 34,13 5,17 51.700 203.181
2012-07-03 2012-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 11.250 11.250
2012-07-03 2012-07-02 4 ISIS ISIS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 1.250 1.250
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -172 29.300 -0,58 11,62 -1.999 340.466
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 172 29.472 0,59 8,15 1.402 240.197
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -1.600 29.300 -5,18 11,60 -18.560 339.880
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.600 30.900 5,46 8,15 13.040 251.835
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -100 29.300 -0,34 11,59 -1.159 339.587
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 100 29.400 0,34 8,15 815 239.610
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -1.500 29.300 -4,87 11,58 -17.373 339.353
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 1.500 30.800 5,12 8,15 12.225 251.020
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -3.500 29.300 -10,67 11,58 -40.530 339.294
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 3.500 32.800 11,95 8,15 28.525 267.320
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -700 29.300 -2,33 11,56 -8.092 338.708
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 700 30.000 2,39 8,15 5.705 244.500
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -495 29.300 -1,66 11,55 -5.717 338.415
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 495 29.795 1,69 8,15 4.034 242.829
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -205 29.300 -0,69 11,54 -2.366 338.122
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 205 29.505 0,70 8,15 1.671 240.466
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -228 29.300 -0,77 11,53 -2.629 337.829
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 228 29.528 0,78 8,15 1.858 240.653
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -500 29.300 -1,68 11,51 -5.755 337.243
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 500 29.800 1,71 8,15 4.075 242.870
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -200 29.300 -0,68 11,50 -2.300 336.950
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 200 29.500 0,68 8,15 1.630 240.425
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 200 29.500 0,68 8,15 1.630 240.425
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -300 29.300 -1,01 11,49 -3.448 336.745
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 300 29.600 1,02 8,15 2.445 241.240
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 300 29.600 1,02 8,15 2.445 241.240
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -200 29.300 -0,68 11,49 -2.298 336.657
2012-06-25 2012-06-25 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -300 29.300 -1,01 11,48 -3.444 336.364
2012-05-22 2012-05-22 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -17.269 0 -100,00
2012-05-22 2012-05-22 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -17.269 29.300 -37,08 9,56 -165.092 280.108
2012-05-22 2012-05-22 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 17.269 46.569 58,94 9,40 162.329 437.749
2012-05-22 2012-05-21 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
M - Exercise -2.731 17.269 -13,66
2012-05-22 2012-05-21 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
S - Sale X -2.731 29.300 -8,53 9,42 -25.726 276.006
2012-05-22 2012-05-21 4 ISIS ISIS PHARMACEUTICALS INC
Common Stock
M - Exercise X 2.731 32.031 9,32 9,40 25.671 301.091
2005-07-06 2005-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 10.000 10.000
2004-07-02 2004-07-01 4 ISIS ISIS PHARMACEUTICALS INC
Director Stock Option (right to buy)
A - Award 10.000 10.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)